Schmid John P.

Director at BridgeBio Oncology Therapeutics, Inc. · on record since Feb 9, 2024
Former Director at BridgeBio Oncology Therapeutics, Inc. · on record since Aug 11, 2025
Director at Helix Acquisition Corp. III · on record since Jan 22, 2026
Director at ANAPTYSBIO, INC · on record since Apr 1, 2026
Director at First Tracks Biotherapeutics, Inc. · on record since Apr 22, 2026
Chief Financial Officer at Trius Therapeutics Inc · on record since Mar 11, 2013
Chief Financial Officer at Auspex Pharmaceuticals, Inc. · on record since Feb 4, 2014
Director at Design Therapeutics, Inc. · on record since Jun 11, 2026
Director at Neos Therapeutics, Inc. · on record since Jul 22, 2015
Director at Xeris Biopharma Holdings, Inc. · on record since Jun 20, 2018
Director at Patient Safety Technologies, Inc · on record since Jul 13, 2020
Director at MoonLake Immunotherapeutics · on record since Oct 19, 2020

Insider trading activity of Schmid John P.

Transactions on record: 168; since Nov 5, 2010

Open-market buys: 7; $149.9K

Open-market sells: 25; $1.2M

Companies traded: 9; last filing Jun 17, 2026

Figures computed from official regulatory filings — methodology.

Companies where Schmid John P. has traded

First Tracks Biotherapeutics, Inc.18 tx · Jun 17, 2026
ANAPTYSBIO, INC49 tx · $2.2M · Jun 17, 2026
Design Therapeutics, Inc.8 tx · $99.8K · Jun 11, 2026
BridgeBio Oncology Therapeutics, Inc.2 tx · Aug 11, 2025
Patient Safety Technologies, Inc18 tx · Jan 8, 2025
Xeris Biopharma Holdings, Inc.22 tx · $50.2K · Aug 13, 2024
Neos Therapeutics, Inc.11 tx · Mar 19, 2021
Auspex Pharmaceuticals, Inc.6 tx · May 6, 2015
Trius Therapeutics Inc34 tx · $3.1M · Sep 13, 2013

Track record of Schmid John P.

Statistical track record

Free

Open-market buys: 7

Last buy: Aug 12, 2024

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of Schmid John P.

Co-insiders of Schmid John P.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Value · USD	Src
ANAPTYSBIO, INC	Jun 17, 2026	Exercise	6,030	—	SEC
ANAPTYSBIO, INC	Jun 17, 2026	ExerciseD	-6,030	—	SEC
First Tracks Biotherapeutics, Inc.	Jun 17, 2026	ExerciseD	-6,030	—	SEC
First Tracks Biotherapeutics, Inc.	Jun 17, 2026	Exercise	6,030	—	SEC
First Tracks Biotherapeutics, Inc.	Jun 12, 2026	AwardD	7,000	$0	SEC
First Tracks Biotherapeutics, Inc.	Jun 12, 2026	AwardD	2,500	$0	SEC
Design Therapeutics, Inc.	Jun 11, 2026	AwardD	30,000	$0	SEC
First Tracks Biotherapeutics, Inc.	May 14, 2026	AwardD	15,000	$0	SEC
First Tracks Biotherapeutics, Inc.	May 14, 2026	AwardD	42,000	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	OtherD	-6,000	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	10,600	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	OtherD	-16,510	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	6,000	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	16,510	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	10,600	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	9,200	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	16,510	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	11,000	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	16,510	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	9,200	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	11,000	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	16,510	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	6,000	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	4,000	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	OtherD	-11,000	$0	SEC

Company	Filed	Type	Qty	Value · USD	Src
ANAPTYSBIO, INC	Jun 17, 2026	Exercise	6,030	—	SEC
ANAPTYSBIO, INC	Jun 17, 2026	ExerciseD	-6,030	—	SEC
First Tracks Biotherapeutics, Inc.	Jun 17, 2026	ExerciseD	-6,030	—	SEC
First Tracks Biotherapeutics, Inc.	Jun 17, 2026	Exercise	6,030	—	SEC
First Tracks Biotherapeutics, Inc.	Jun 12, 2026	AwardD	7,000	$0	SEC
First Tracks Biotherapeutics, Inc.	Jun 12, 2026	AwardD	2,500	$0	SEC
Design Therapeutics, Inc.	Jun 11, 2026	AwardD	30,000	$0	SEC
First Tracks Biotherapeutics, Inc.	May 14, 2026	AwardD	15,000	$0	SEC
First Tracks Biotherapeutics, Inc.	May 14, 2026	AwardD	42,000	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	OtherD	-6,000	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	10,600	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	OtherD	-16,510	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	6,000	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	16,510	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	10,600	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	9,200	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	16,510	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	11,000	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	16,510	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	9,200	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	11,000	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	16,510	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	6,000	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	4,000	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	OtherD	-11,000	$0	SEC